Septic Shock After Allogeneic Hematopoietic Stem Cell Transplantation
CHEST · 2026-08
DOI: 10.1016/j.chest.2026.06.075 ↗Kurz gefasst
Fachartikel in der Zeitschrift CHEST, 2026-08. Verfasst von Marielle Subileau und 21 weiteren Autor:innen. Beteiligte Einrichtung: Service de Médecine Intensive et Réanimation, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Université Paris-Cité, Paris, France. Ele…. Die Arbeit nennt 54 Literaturangaben.
Themen: Sepsis
Abstract (Originalsprache)
BACKGROUND: Septic shock is a major cause of ICU admission among recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT), yet data on its epidemiologic features and prognosis remain limited. RESEARCH QUESTION: What are the outcomes, independent prognostic factors, and associations of allo-HSCT that may inform early management? STUDY DESIGN AND METHODS: We performed a multicenter retrospective cohort study including recipients of allo-HSCT admitted to the ICU with septic shock between 2015 and 2020. RESULTS: Among 1,164 recipients of allo-HSCT hospitalized in ICU, 38% (n = 444) were admitted for septic shock. The median Sequential Organ Failure Assessment (SOFA) score was 8 (interquartile range, 6-11). Microbiological documentation was obtained in 62% (n = 261), including fungal pathogens in 17% (n = 74). The respiratory tract was the most common infection source (43%; n = 180). Invasive mechanical ventilation and renal replacement therapy were required in 64% (n = 284) and 32% (n = 143), respectively. Mortality at 90 days and 3 years was 63% (n = 280) and 81% (n = 350), respectively. In the extended Cox model, fungal documentation (hazard ratio [HR], 1.78 [95% CI, 1.19-2.67]; P = .005), SOFA score (HR, 1.07 [95% CI, 1.02-1.13]; P = .007), and neutropenia (HR, 3.94 [95% CI, 1.18-13.1]; P = .026) were associated independently with 90-day survival. In a 48-hour landmark analysis, early aminoglycoside use was associated with higher 90-day survival (HR, 0.46 [95% CI, 0.33-0.64]; P < .001). However, time-varying analyses indicated a nonconstant association over time. Age of ≥ 56 years (HR, 1.36 [95% CI, 0.99-1.87]), graft-versus-host disease type, and early bacterial documentation (HR, 0.90 [95% CI, 0.64-1.26]) were not associated with 90-day survival. INTERPRETATION: Our results show that septic shock after allo-HSCT carries a high mortality (63% at 90 days), largely driven by host-related factors and initial illness severity. The association between aminoglycoside use and outcome is complex, does not support a straightforward causal interpretation, and warrants further prospective evaluation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service de Médecine Intensive et Réanimation, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Université Paris-Cité, Paris, France. Electronic address: marielle.subileau@aphp.fr.
- Service de Médecine Intensive et Réanimation, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Université Paris-Cité, Paris, France; Service de Réanimation Polyvalente, Centre Hospitalier de Laval, Laval, F…
- Service de Médecine Intensive et Réanimation, Assistance Publique - Hôpitaux de Paris, Hôpital Saint Louis, Université Paris-Cité, Paris, France.
- Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Nantes Université, Nantes, France.
- Service de Médecine Intensive et Réanimation, Centre Hospitalier Universitaire de Lille, Lille, France.
- Service de Réanimation Polyvalente, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Zitieren
APA
Subileau, M., Chean, D., Dupont, T., Canet, E., Moreau, A. S., Picard, M., Mokart, D., Platon, L., Mayaux, J., Wallet, F., Issa, N., Raphalen, J. H., Pène, F., Renault, A., Arnales, D., Van De Wyngaert, C., Kemp, H., Xhaard, A., Bigé, N., …, & Lafarge, A. (2026). Septic Shock After Allogeneic Hematopoietic Stem Cell Transplantation. CHEST. https://doi.org/10.1016/j.chest.2026.06.075
Vancouver
Subileau M, Chean D, Dupont T, Canet E, Moreau AS, Picard M, et al. Septic Shock After Allogeneic Hematopoietic Stem Cell Transplantation. CHEST. 2026. doi:10.1016/j.chest.2026.06.075
BibTeX
@article{Subileau2026,
author = {Subileau, Marielle and Chean, Dara and Dupont, Thibault and Canet, Emmanuel and Moreau, Anne-Sophie and Picard, Muriel and Mokart, Djamel and Platon, Laura and Mayaux, Julien and Wallet, Florent and Issa, Nahema and Raphalen, Jean-Herlé and Pène, Frédéric and Renault, Anne and Arnales, Delphine and Van De Wyngaert, Caroline and Kemp, Hélène and Xhaard, Aliénor and Bigé, Naike and Darmon, Michaël and Azoulay, Elie and Lafarge, Antoine},
title = {Septic Shock After Allogeneic Hematopoietic Stem Cell Transplantation},
journal = {CHEST},
year = {2026},
doi = {10.1016/j.chest.2026.06.075}
}
EUVIMED